First Patients Enrolled into the MOCA I Trial
CorFlow Therapeutics AG ("CorFlow") today announced that the first two patients have been enrolled into the First-in-Man…
CorFlow Therapeutics AG ("CorFlow") today announced that the first two patients have been enrolled into the First-in-Man…
CorFlow Therapeutics AG ("CorFlow") announced that the US Patent Office (USPTO) this week granted the company it's first…
CorFlow Therapeutics AG ("CorFlow") today announced that the company will present the Controlled Flow Infusion (CoFI™) t…
CorFlow Therapeutics AG ("CorFlow") today announced that the Swiss competent authority, Swissmedic, and the Swiss ethics…
CorFlow Therapeutics AG ("CorFlow") today announced that it is restructuring it's management team. It is with great ple…
CorFlow Therapeutics AG ("CorFlow") today announced that Innosuisse, the Swiss Innovation Agency, has awarded the Compan…